Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Montelukast/ranitidine

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Iannelli M, et al. Long term treatment with omalizumab in adolescent with refractory solar urticaria. Italian Journal of Pediatrics 47 : 1-4, No. 1, Dec 2021. Available from: URL: http://www.ijponline.net/ Iannelli M, et al. Long term treatment with omalizumab in adolescent with refractory solar urticaria. Italian Journal of Pediatrics 47 : 1-4, No. 1, Dec 2021. Available from: URL: http://​www.​ijponline.​net/​
Metadaten
Titel
Montelukast/ranitidine
Lack of efficacy: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41114-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Ruxolitinib

Case report

Brolucizumab

Case report

Immune-globulin

Case report

Multiple drugs

Case report

Multiple drugs